| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions refers to ophthalmology. The ophthalmic preparations are used in ophthalmic diseases as a lacrimal substitute, and they contain a combination of hyaluronic acid and a polysaccharide known as TSP (a Tamarindus indica seed polysaccharide). The ophthalmic preparations suggested to be used in treating a dry eye syndrome contain in a combination of 0.05 to 2 wt % of the tamarind seed polysaccharide and 0.05 to 1 wt % of hyaluronic acid in the aqueous solution.EFFECT: when administered in a combination of hyaluronic acid and TSP, the invention provides a synergistic effect in stimulating the normal conjunctival mucosa recovery if affected by the dry eye syndrome, thereby inducing a noticeable improvement of the number and morphology of the conjunctival microvilli.16 cl, 9 tbl, 6 dwg |
